An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), has developed the drug, in collaboration with Dr Reddy’s Laboratories, Hyderabad.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by day-3 in comparison to SOC, indicating an early relief from oxygen therapy/dependence. The drug comes in the form of a powder in a sachet & is supposed to be dissolved in water.
Important takeaways for all competitive exams:
Our Earth has seven continents and each one is different in its land, weather and…
Income Tax Department of India has launched a new platform called 'Kar Saathi'. It is…
The remarkable conservation success story of blackbucks coming from the State of Chhattisgarh. The state…
Hobbies are those activities that people do in their free time for enjoyment and relaxation.…
The Project Chetak by the Border Roads Organization celebrated the 47th Raising Day in Bikaner.…
The Chetak Screen Awards 2026 celebrated the best performance of the Indian cinema with the…